Abaloparatide (Tymlos) Explained: The Second FDA-Approved Bone-Builder
Osteoporosis drugs have a reputation problem. Most people picture them as bone-preserving at best — slowing breakdown, not adding new tissue. That impression is accurate for bisphosphonates, which is exactly why a second FDA-approved anabolic peptide often surprises people. If your doctor mentioned abaloparatide, your first questions are probably: Is this just another version of […]
Abaloparatide (Tymlos) Explained: The Second FDA-Approved Bone-Builder Read More »









